ALBIX Trademark

Trademark Overview


On Wednesday, October 9, 2013, a trademark application was filed for ALBIX with the United States Patent and Trademark Office. The USPTO has given the ALBIX trademark a serial number of 79141004. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, October 8, 2023. This trademark is owned by Novozymes Biopharma DK A/S. The ALBIX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents

[ Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; ] albumin for use in the manufacture of pharmaceuticals, vaccines, medical substances and cell therapy preparations; chemical substances for use in diagnostic kits, namely, albumin blocking agents used to bind to test kit surfaces to prevent non-specific binding of test substances to the surface [ ; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations ]

Scientific and technological research and development services for new products and uses in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; consultancy services regarding product research and product development in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cell research; advisory services with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; providing expert analysis with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cells * in the field of development of medicines and pharmaceutical products *; and scientific development and analysis in the fields of pharmaceuticals, vaccines, and drug discoveries; all relating to * the use of albumin in * science, biotechnology, biochemi...
albix

General Information


Serial Number79141004
Word MarkALBIX
Filing DateWednesday, October 9, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, October 8, 2023
Registration Number4607782
Registration DateTuesday, September 23, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 8, 2014

Trademark Statements


Certificate of Correction for RegistrationLine 33, "in the field of development of medicines and pharmaceutical products" should be inserted after "cells" in class 42.
Goods and ServicesPharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents
Certificate of Correction for RegistrationIn the Statement, Page 1, lines 5 - 11, "Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; " should be deleted, and, In the Statement, Page 1, lines 15-17, "; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations" should be deleted, and, In the Statement, Page 1, line 19, after reagents, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 1, line 20 after REAGENTS, "for medical use" should be inserted, and, In the Statement, Page 1, line 20, after PROTEINS, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 1, line 20, after ALBUMIN, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 1, line 20, after, RECOMBINANT ALBUMIN, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 2, line 1, after ALL RELATING TO, "the use of albumin in" should be inserted.
Goods and Services[ Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; ] albumin for use in the manufacture of pharmaceuticals, vaccines, medical substances and cell therapy preparations; chemical substances for use in diagnostic kits, namely, albumin blocking agents used to bind to test kit surfaces to prevent non-specific binding of test substances to the surface [ ; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations ]
Goods and ServicesScientific and technological research and development services for new products and uses in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; consultancy services regarding product research and product development in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cell research; advisory services with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; providing expert analysis with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cells * in the field of development of medicines and pharmaceutical products *; and scientific development and analysis in the fields of pharmaceuticals, vaccines, and drug discoveries; all relating to * the use of albumin in * science, biotechnology, biochemistry, biology, medicine and pharmaceuticals

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 9, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 9, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlbumedix Ltd
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressGB

Party NameAlbumedix A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK

Party NameNovozymes Biopharma DK A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK

Party NameNovozymes Biopharma DK A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Thursday, January 2, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, January 8, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 14, 2014APPLICATION FILING RECEIPT MAILED
Saturday, January 25, 2014ASSIGNED TO EXAMINER
Saturday, February 1, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 3, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 22, 2014REFUSAL PROCESSED BY IB
Monday, May 26, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, January 31, 2014NON-FINAL ACTION WRITTEN
Monday, February 3, 2014REFUSAL PROCESSED BY MPU
Wednesday, February 19, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 19, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 26, 2014EXAMINERS AMENDMENT E-MAILED
Monday, May 26, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 18, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 2, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 27, 2014ASSIGNED TO LIE
Tuesday, May 27, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, May 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 5, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 2, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, July 8, 2014PUBLISHED FOR OPPOSITION
Tuesday, July 8, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2014REGISTERED-PRINCIPAL REGISTER
Friday, February 27, 2015FINAL DISPOSITION PROCESSED
Tuesday, July 22, 2014NOTIFICATION PROCESSED BY IB
Thursday, October 30, 2014LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, November 19, 2014LIMITATION FROM THE IB EXAMINED AND ENTERED
Wednesday, November 19, 2014ASSIGNED TO PARALEGAL
Wednesday, November 19, 2014CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, December 23, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, February 28, 2016CORRECTION UNDER SECTION 7 - PROCESSED
Friday, February 27, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 20, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 20, 2015PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, August 20, 2015INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, October 22, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 22, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2016LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, February 24, 2016LIMITATION FROM THE IB EXAMINED AND ENTERED
Friday, February 26, 2016NEW REPRESENTATIVE AT IB RECEIVED
Monday, September 23, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, April 27, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2016PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, November 9, 2016INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, July 13, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 1, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, October 11, 2018CHANGE OF OWNER RECEIVED FROM IB
Thursday, January 24, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, March 14, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 4, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 9, 2021CANCELLED SECTION 71
Friday, April 23, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, December 9, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 22, 2022INVALIDATION PROCESSED
Friday, April 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, January 29, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 6, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, May 6, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, May 6, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED